Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats

European Journal of Pharmacology

Volumn 321, Issue 3, 1997, Pages 325-332

  Kinoshita, Mine ^a   Saito, Nobuko ^a   Tamaki, Hajime ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Gastric acid secretion; H+ K+ ATPase; Omeprazole; Ranitidine; T 330

Indexed keywords

BUCLADESINE; DIMAPRIT; OMEPRAZOLE; PENTAGASTRIN; PROTON PUMP INHIBITOR; RANITIDINE; T 330; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FISTULA; IN VITRO STUDY; INTRADUODENAL DRUG ADMINISTRATION; INTRAGASTRIC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; STOMACH LESION; STOMACH MUCOSA;

ANIMALS; ANTI-ULCER AGENTS; ENZYME INHIBITORS; ESOPHAGITIS, PEPTIC; GASTRIC ACID; GASTRIC FISTULA; GASTRIC MUCOSA; H(+)-K(+)-EXCHANGING ATPASE; HISTAMINE H2 ANTAGONISTS; IMIDAZOLES; MALE; OMEPRAZOLE; PEPTIC ULCER; PYRIDINES; RANITIDINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031059335     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00958-2     Document Type: Article

References (29)

1. Anson, M.L., 1938, The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin, J. Gen. Physiol. 22, 79.
2. Betton, G.R., C.S. Dormer, T. Wells, P. Pert, C.A. Price and P. Buckley, 1988, Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H ,-antagonists SK&F93479 and oxmetidine and omeprazole, Toxicol. Pathol. 16, 288.
3. 2-receptor Antagonists, ed. W.L. Burland and M.A. Simkins (Excerpta Medica, Amsterdam) p. 224.
4. Carlsson, E. 1989, A review of the effects of long-term acid inhibition in animals, Scand. J. Gastroenterol. 24 (Suppl. 166), 19.
5. Carlsson, E., H. Larsson, H. Mattsson, B. Ryberg and G. Sundell, 1986, Pharmacology and toxicology of omeprazole with special reference to the effects on the gastric mucosa, Scand. J. Gastroenterol. 21 (Suppl. 118), 31.
6. Freston, F.W., K. Borch, S.J. Brand, E. Carlsson, W. Creutzfeldt, R. Hakanson, L. Olbe, E. Solcia, J.H. Walsh and M.M. Wolfe, 1995, Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells: a review and analysis, Dig. Dis. Sci. 40 (Suppl.), 50S.
7. +-adenosine triphosphatase a subunit and its effect on inhibition of rata gastric acid secretion, Gastroenterology 109, 1134.
8. Groves, W.G., J.H. Schlosser and F.D. Mead, 1974, Acid hypersecretion and duodenal ulcers produced by cysteamine in rats, Res. Commun. Chem. Pathol. Pharmacol. 9, 523.
9. +-ATPase inhibitors, Prog. Med. Chem. 31, 233.
10. Hersey, S.J. and G. Sachs, 1995, Gastric acid secretion, Physiol. Rev. 75, 155
11. Hirschowitz, B.I., D. Keeling, M. Lewin, S. Okabe, M. Parsons, K. Sewing, B. Wallmark and G. Sachs, 1995, Pharmacological aspects of acid secretion, Dig. Dis. Sci. 40, 3S.
12. Hunt, R.H., C. Cederberg, J. Dent, F. Halter, C. Howden, I.N. Solly Marks, S. Rune and R.P. Walt, 1995, Optimizing acid suppression for treatment of acid-related diseases, Dig. Dis. Scei. 40, 24S.
13. +)-ATPase in vivo by omeprazole, Biochem. Biopys. Res. Commun. 126, 78.
14. Inatomi, N., H. Nagaya, K. Takami, A. Shino and H. Satoh, 1991, Effects of a proton pump inhibitor, AG-1749 (Lansoprazole), on reflux esophagitis and experimental ulcers in rats, Jpn. J. Pharmacol. 55, 437.
15. +-ATPase by T-330; 2-[(2-dimethyl-aminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole, J. Pharmacol. Exp. Ther. 277, 28.
16. Lamberts, R., W. Creutzfeldt, F. Stockmann, U. Jacubaschke, S. Mass and G. Brunner, 1988, Long-term omeprazole treatment in man: effects in gastric endocrine cell populations, Digestion 39, 126.
17. Lamberts, R., W. Creutzfeldt, H.G. Strüber, G. Brunner and E. Solcia, 1993, Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis, Gastroenterology 104, 1356.
18. Larner, A.J. and R. Lendrum, 1992, Oesophageal candidiasis after omeprazole therapy, Gut 33, 860.
19. Larsson, H., E. Carlsson, U. Junggren, L. Olbe, S.E. Sjöstrand, I. Skånberg and G. Sundell, 1983, Inhibition of gastric acid secretion by omeprazole in the dog and rat, Gastroenterology 85, 900.
20. Lewin, M., A.M. Cheret and G. Sachs, 1982, Separation of individual cells from the fundic gastric mucosa, in: Cell Separation, ed. T.G. Pretlow and T.P. Pretlow (Academic Press, New York, NY) p. 223.
21. Lindberg, P., A. Brändström, B. Wallmark, H. Mattsson, L. Rikner and K. Hoffmann, 1990, Omeprazole: the first proton pump inhibitor, Med. Res. Rev. 10, 1.
22. +-transporting ATPase: a new class of anti-secretory agent, Trends Pharmacol. Sci. 14, 323.
23. 2-blockade and gastric carcinoid tumors in the rats, Gut 26, 1284.
24. Satoh, H., N. Inatomi, H. Nagaya, I. Inada, A. Nohara, N. Nakamura and Y. Maki, 1989, Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats, J. Pharmacol. Exp. Ther. 248, 806.
25. Sewing, K., P. Harms, G. Schulz and H. Hannemann, 1983, Effect of substituted benzimidazoles on acid secretion in isolated and enriched guinea pig parietal cells, Gut 24, 557.
26. Szabo, S., L.R. Haith and E.S. Reynolds, 1979, Pathogenesis of duodenal ulceration produced by cysteamine or propionitrile: Influence of vagotomy, sympathectomy, histamine depletion, H-2 receptor antagonists and hormones, Dig. Dis. Sci. 24, 471.
27. Wingate, D.L., 1990, Acid reduction and recurrent enteritis, Lancet 335, 222.
28. +-ATPase inhibitor. J. Med. Chem. 39, 596.
29. Yamamoto, O., Y. Okada and S. Okabe, 1984, Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats, Dig. Dis. Sci. 29, 394.